SGS is now officially part of SGS North America!  We’ll now be known as SGS (SGS), and you’ll continue to receive the same level of service – and more – that you’ve come to trust and expect from CSL over the years. On May 3, 2019, SGS… Read More >

The Future is…BIGGER!

Even after moving to our current location in the fall of 2015, we’ve had dreams of expanding CSL’s borders- literally. With the new year upon us, we’ve began the process of renovating the front of our building into a new space for our employees and visitors. Here are pics of the new front area after… Read More >

The Benefit of Interlaboratory Studies

Product testing and compliance have both been a recent topic in the news, particularly in regards to the safety of consumer products in both the pharmaceutical and dietary supplement industries. It has brought to light a question to many consumers: Are these companies even testing what they produce? In reality, companies in these industries have… Read More >

Gummies and Chocolates and Mints, OH MY!

After being in business for over 21 years, we see thousands of samples come through our doors. One of the more interesting (and delicious) type of sample is the candy our clients send us to test. We’ve seen everything from fruit-flavored gummies to chocolate to peppermints- and all for good reason. Candy Concern In 1994,… Read More >

CSL Adds USP <1660> to Repertoire of Testing

In response to the most recent revision for USP <1660> Evaluation of the Inner Surface Durability of Glass Containers, SGS has taken the lead in optimizing, validating and supporting the newest recommendations of applying the ICP impurities testing portion of the standard to meet current guidelines. What’s the big deal? The… Read More >

Explaining the “Naturally Occurring” Exemption in Prop 65

The updated Proposition 65 requirements have been one of the most-discussed topics in the natural products industry in 2018. Since you’ve heard about them so much, you probably have them memorized. You know that businesses are required to provide “clear and reasonable” warnings on products that expose consumers to any of the 900 chemicals listed…. Read More >

USP 232/233

PDE, MDD and USP <232><233>

As we work with numerous pharma companies in performing screenings of drug products and their excipients/APIs, validations of methods, and/or conducting release/routine testing, a common point of discussion is the Maximum Daily Dose (MDD) or daily Serving Size. MDD is directly correlated with the Permitted Daily Exposure (PDE).  As many are aware, USP <232> defines… Read More >

USP 232/233

Your Guide to USP 232/233 – Changes to Testing for Elemental Impurities in Drug Products

We’re less than a month away from the deadline to comply with the USP General Chapters <232>/<233>, pertaining to Elemental Impurities in all drug products. Many of our customers are racing to implement the steps for compliance, including performing Risk Assessments, Validations and/or Verifications of methods for testing individual products, and Release Testing. Chemical Solutions… Read More >

USP 232/233

USP 232/233 – Contending with the looming January 1st deadline

Many of our Pharma clients are facing a common issue – how to complete risk assessments and validate methods for their raw materials and finished products – prior to the January 1, 2018 deadline. Over the past few years, CSL has been conducting matrix and element-specific validations and verifications for the pharmaceutical industry.  If you’ve… Read More >

SGS Tackles DMSO

In the trace elemental analysis industry, it is not uncommon for us to come across substances that we know will be complicated to analyze. At SGS, we don’t toss around the word “impossible” in our lab. We welcome challenges by having a “Bring It On” type of attitude. So, when we… Read More >

Sign up for Our Blog

* = required field

Most Recent Blog Posts